Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges (P13-5.017)
Article
Ayzenberg, Ilya, Asseyer, Susanna, Lindenblatt, Gero, Fischer, Katinka, Pul, Refik, Özalp, Sinem-Hilal, Lohmann, Lisa, Giglhuber, Katrin, Häussler, Vivien, Karenfort, Michael, Hellwig, Kerstin, Paul, Friedemann, Bellmann-Strobl, Judith, Otto, Carolin, Ruprecht, Klemens, Ziemssen, Tjalf, Emmer, Alexander, Rothhammer, Veit, Nickel, Florian, Angstwurm, Klemens, Linker, Ralf, Warnke, Clemens, Jarius, Sven, Korporal-Kuhnke, Mirjam, Wildemann, Brigitte, Wolff, Stephanie, Seipelt, Maria, Yalachkov, Yavor, Retzlaff, Nele, Zettl, Uwe, Rommer, Paulus, Kowarik, Markus, Wickel, Jonathan, Geis, Christian, Hümmert, Martin W., Trebst, Corinna, Senel, Makbule, Klotz, Luisa, Gold, Ralf, Kleinschnitz, Christoph, Meuth, Sven, Aktas, Orhan, Berthele, Achim and Ringelstein, Marius (2023) Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges (P13-5.017). Neurology 100 (17_sup).Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Neurology | ||||
| Publisher | LIPPINCOTT WILLIAMS & WILKINS | ||||
| Place of Publication | PHILADELPHIA | ||||
| Volume | 100 | ||||
| Number of Issue or Book Chapter | 17_sup | ||||
| Date | 2023 | ||||
| Date of publication | 18 Mar 2025 10:11 | ||||
| Institutions | Medicine > Lehrstuhl für Neurologie | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 76218 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric